167 related articles for article (PubMed ID: 7642973)
21. [Predictors of recurrence after pancreaticoduodenectomy for carcinoma of the ampulla of Vater].
Chen J; Cai S; Dong J
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1242-4. PubMed ID: 22985555
[TBL] [Abstract][Full Text] [Related]
22. Factors predicting adequate lymph node yield in patients undergoing pancreatoduodenectomy for malignancy.
Sierzega M; Bobrzyński Ł; Matyja A; Kulig J
World J Surg Oncol; 2016 Sep; 14(1):248. PubMed ID: 27644962
[TBL] [Abstract][Full Text] [Related]
23. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
24. Carcinoma of the pancreas and papilla of Vater--assessment of resectability and factors influencing resectability in stage I carcinomas. A prospective multicentre trial in 472 patients.
Bakkevold KE; Arnesjø B; Kambestad B
Eur J Surg Oncol; 1992 Oct; 18(5):494-507. PubMed ID: 1426302
[TBL] [Abstract][Full Text] [Related]
25. Predictors of long-term survival following resection for ampullary carcinoma: a large retrospective French multicentric study.
Robert PE; Leux C; Ouaissi M; Miguet M; Paye F; Merdrignac A; Delpero JR; Schwarz L; Carrere N; Muscari F; Gayet B; Dussart D; Hamy A; Regenet N
Pancreas; 2014 Jul; 43(5):692-7. PubMed ID: 24713843
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
Park JS; Yoon DS; Kim KS; Choi JS; Lee WJ; Chi HS; Kim BR
J Surg Oncol; 2007 Mar; 95(4):286-90. PubMed ID: 17326125
[TBL] [Abstract][Full Text] [Related]
27. Tumor of the ampulla of Vater: experience with local or radical resection in 171 consecutively treated patients.
Beger HG; Treitschke F; Gansauge F; Harada N; Hiki N; Mattfeldt T
Arch Surg; 1999 May; 134(5):526-32. PubMed ID: 10323425
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological and operative factors for prognosis of carcinoma of the ampulla of vater.
Inoue Y; Hayashi M; Hirokawa F; Egashira Y; Tanigawa N
Hepatogastroenterology; 2012; 59(117):1573-6. PubMed ID: 22683975
[TBL] [Abstract][Full Text] [Related]
29. Factors influencing lymph node metastasis in patients with ampullary adenocarcinoma.
Okano K; Asano E; Kushida Y; Kamada H; Mori H; Suzuki Y
Dig Surg; 2014; 31(6):459-67. PubMed ID: 25613423
[TBL] [Abstract][Full Text] [Related]
30. Surgical Strategy for T1 Duodenal or Ampullary Carcinoma According to the Depth of Tumor Invasion.
Kohga A; Yamamoto Y; Sano S; Sugiura T; Okamura Y; Ito T; Ashida R; Ishiwatari H; Matsubayashi H; Sasaki K; Uesaka K
Anticancer Res; 2017 Sep; 37(9):5277-5283. PubMed ID: 28870965
[TBL] [Abstract][Full Text] [Related]
31. [Significance of occult lymphatic tumor spread in pancreatic cancer].
Milsmann C; Füzesi L; Werner C; Becker H; Horstmann O
Chirurg; 2005 Nov; 76(11):1064-72. PubMed ID: 15971035
[TBL] [Abstract][Full Text] [Related]
32. Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment.
Kwon J; Kim K; Chie EK; Kim BH; Jang JY; Kim SW; Oh DY; Bang YJ
Eur J Surg Oncol; 2017 Sep; 43(9):1690-1696. PubMed ID: 28648977
[TBL] [Abstract][Full Text] [Related]
33. [Comparison of endoscopic ultrasonography with computer-assisted tomography in the determination of preoperative stage and resectability of pancreatic and ampullary cancers].
Lu ZC; Guo JM; Zhang YL; Tian PL; Zhang L; Yu JP; Bao XY
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):441-4. PubMed ID: 17152491
[TBL] [Abstract][Full Text] [Related]
34. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
35. Ampullary region carcinomas: definition and site specific classification with delineation of four clinicopathologically and prognostically distinct subsets in an analysis of 249 cases.
Adsay V; Ohike N; Tajiri T; Kim GE; Krasinskas A; Balci S; Bagci P; Basturk O; Bandyopadhyay S; Jang KT; Kooby DA; Maithel SK; Sarmiento J; Staley CA; Gonzalez RS; Kong SY; Goodman M
Am J Surg Pathol; 2012 Nov; 36(11):1592-608. PubMed ID: 23026934
[TBL] [Abstract][Full Text] [Related]
36. [Malignant tumors of the ampulla of Vater. Results of radical excision. A study of 39 cases].
Sielezneff I; Lécuyer J; Pirro N; Césari J; Brunet C; Sastre B
Chirurgie; 1998 Dec; 123(6):560-7. PubMed ID: 9922595
[TBL] [Abstract][Full Text] [Related]
37. Flow cytometric studies on the relationship between DNA content and clinicopathologic features of pancreatic cancers.
Bocsi J; Berczi C; Balázs G; Lapis K
Anticancer Res; 1998; 18(3A):1839-43. PubMed ID: 9673413
[TBL] [Abstract][Full Text] [Related]
38. Long-term survival following radical and palliative treatment of patients with carcinoma of the pancreas and papilla of Vater--the prognostic factors influencing the long-term results. A prospective multicentre study.
Bakkevold KE; Kambestad B
Eur J Surg Oncol; 1993 Apr; 19(2):147-61. PubMed ID: 7684003
[TBL] [Abstract][Full Text] [Related]
39. Prognostic analysis of carcinoma of the ampulla of Vater: pancreaticoduodenectomy versus local resection.
Feng J; Zhou X; Mao W
Hippokratia; 2012 Jan; 16(1):23-8. PubMed ID: 23930053
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer].
Roder JD; Siewert JR
Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
